throbber
Eur. J. Immunol. 1980. 20: 467-476
`
`Immunoglobulin M mutants
`
`467
`
`11 Kohler, G., Hengartner, H. and Milstein, C., Protides Biol. Fluids
`Proc. Colloq. 1978. 25: 545.
`12 Galfrt, G., Milstein, C. and Wright, B. W., Nature 1979.277: 131.
`13 Galfrt, G., Howe, S. C., Milstein, C., Butcher, G. W. and How-
`ard, J. C., Nature 1977. 266: 550.
`14 Littlefield, J. W., Science 1964. 145: 709.
`15 Cotton, R. G. H., Secher, D. S. and Milstein, C., Eur. J.
`Immunol. 1973. 3: 136.
`16 Mechler, B. and Vassalli, P., J. Cell Biol. 1975. 67: 1.
`17 Cory, S. and Adams, J. M., J. Mol. Biol. 1975. 99: 579.
`18 Pelham, H. R. B. and Jackson, R. J., Eur. J. Biochem. 1976. 67:
`247.
`19 Lisowska-Bernstein, B., Lamm, M. E. and Vassalli, P., Proc. Nar.
`Acad. Sci. USA 1970. 66: 425.
`20 Baglioni, C. and Liberti, P., Mol. Biol. Rep. 1974. I: 329.
`21 Okuyama, A,, McInnes, J., Green, M. and Pestka, S., Biochem.
`Biophys. Res. Commun. 1977. 77: 347.
`
`22 Sakano, H., Rogers, J. H., Hiippi, K., Brack, C., Traunecker, A,,
`Maki, R., Wall, R. and Tonegawa, S., Nature 1979. 277: 627.
`23 Early, P. W., Davis, M. M., Kaback, D. B., Davidson, N. and
`Hood, L., Proc. Nat. Acad. Sci. USA 1979. 76: 857.
`24 Morrison, S. L., Eur. J. Immunol. 1978. 8: 194.
`25 Fleischman, J. M., Porter, R. R. and Press, E. M., Biochem. J .
`1963. 88: 200.
`26 Margulies, D. H., Kuehl, W. M. and Scharff, M. D., Cell 1976. 8:
`405.
`27 Kohler, G. and Milstein, C., Nature 1975. 256: 495.
`28 Mosmann, T. R., Baumal, R. and Williamson, A. R., Eur. J.
`Itnmunol. 1979. 9: 511.
`29 Kohler, G., Hengartner, H. and Shulrnan, M. J., Eur. J. Immunol.
`1978. 8: 82.
`30 Howard, J. C., Butcher, G. W., GalfrC, G., Milstein, C. and Mil-
`stein, C. P., Immunol. Rev. 1979. 47: 139.
`
`Georges Kohler and Marc J. Shulman'
`
`Immunoglobulin M mutants
`
`Basel Institute for Immunology, Basel
`
`Mutants of a hybridoma line secreting IgM with anti-trinitrophenyl specificity were
`enriched by coupling the hapten to the cell surface and incubating the cells in the
`presence of complement. In this way, cells secreting wild-type Ig commit suicide,
`whereas cells secreting IgM with reduced lytic activity preferentially survive.
`Mutants have been isolated which showed no or reduced synthesis of either the heavy
`or the light chain of the IgM molecule, mutants with internal and carboxy-terminal
`deletions of the p chain, and a mutant with an electrophoretically silent change of the
`p chain that reduces the affinity of the antibody for the hapten tenfold. The frequency
`to lo-'. All
`of mutants in the original population was estimated to be about
`mutants were stable with reversion frequencies of about
`or less.
`
`1 Introduction
`
`Immunoglobulin (Ig) production involves many steps: activa-
`tion of the Ig genes, transcription of these genes into RNA,
`RNA processing and translation into the Ig heavy (H) and
`light (L) chains, H and L chain assembly, glycosylation, and
`secretion. The resulting mature Ig themselves have several
`functions such as antigen binding, and, depending on the Ig
`class, complement fixation or Fc receptor binding.
`
`Many of the phenomena related to Ig production and function
`can be conveniently studied in tissue culture, using cell lines
`derived from myelomas and hybridomas for which Ig com-
`prises a major part of the total protein. Furthermore, using
`such cell lines, the biochemical basis of these phenomena can
`
`[I 27351
`Present address: Laboratory of Cell Biology, Rheumatic Disease
`Unit, Wellesley Hospital, Toronto, Ontario M4Y 1 J 3, Canada
`
`Correspondence: Georges Kohler, Basel Institute for Immunology,
`487 Grenzacher StraBe, Postfach, CH-4005 Basel 5, Switzerland
`
`Abbreviations: DF, IF, BSS-G, T medium, PBS and HAT: see Sect. 2.1
`SDS-PAGE: Sodium dodecyl sulfate polyacrylamide gel electro-
`phoresis TNP: 2,4,6-Trinitrophenyl TNBS: 2,4,6-Trinitrobenzene sul-
`fonic acid IEF: Isoelectric focusing SRC: Sheep red cells PFC: Plaque-
`forming cells C: Complement FACS: Fluorescence-activated cell
`sorter
`
`0 Verlag Chemie, GmbH, D-6940 Weinheim, 1980
`
`be elucidated by comparing the constituents of normal cells
`and mutants that are defective in some aspect of Ig production
`and function.
`
`Studying mutants affecting Ig synthesis in hybridoma cells has
`several advantages over other mammalian systems. The struc-
`ture of Ig and its basic gene organization [ 1 4 ] are known. The
`large amount of secreted Ig makes it easy to collect enough
`material for biochemical studies, and antigen-specific plaque
`assays allow the detection of single antibody-secreting cells.
`Another advantage is the fact that the synthesis of most other
`proteins results from the expression of both of the two
`chromosomes of diploid cells, and for such proteins most
`mutations will, therefore, be recessive. Only one of the two
`chromosomes directs Ig synthesis [7]. The other chromosome
`is silent, a phenomenon called allelic exclusion. Therefore,
`one could expect mutants in the Ig genes to be more easily
`obtainable than mutants defective in other proteins. This also
`implies that mutations in regulatory genes affecting Ig synthe-
`sis must be of the rare dominant type or they will remain
`unnoticed. Therefore, all mutants including the so-called reg-
`ulatory ones affecting, for example, the amounts of Ig, will
`most likely be alterations in the genes coding for the Ig L and
`H chains.
`
`The isolation of cells mutated in genes for nonessential pro-
`teins, such as Ig, has so far required single cell-screening
`techniques. For example, Scharff and his colleagues [8, 91 dis-
`cerned mutant clones making altered Ig by testing for anti-
`
`0014-298018010606-0467$02.5010
`
`Mylan v. Genentech
`IPR2016-00710
`Merck Ex. 1118, Pg. 1
`
`

`

`468
`
`G. Kohler and M. J. Shulrnan
`
`Eur. J. Immunol. 1980. 10: 467-476
`
`body-dependent precipitation around colonies in agar. Cotton
`et al. [lo] tested the isoelectric focusing (IEF) pattern of Ig
`secreted by individual myeloma clones. The maximal screen-
`ing capacity is about lo5 individual clones in the former exam-
`ple and lo4 individual clones in the latter. More recently, the
`fluorescence-activated cell sorter (FACS) has been used to
`enrich for rare variants representing one cell among lo4 in the
`initial culture [ll]. We have devised a selection procedure
`which depends on the secretion of cytolytic antibody and takes
`advantage of its antigen-binding specificity. In short, the anti-
`gen is coupled to the surface of the antibody-secreting cell, and
`the cells are then incubated in the presence of complement.
`Cells secreting wild-type antibodies commit suicide, whereas
`mutants which, e.g., secrete antibodies with reduced antigen-
`binding capacity survive and are thus enriched. Using this
`selection procedure in conjunction with single cell-screening
`techniques, we were able to screen relatively rapidly and easily
`about lo6 cells and to derive five distinct mutant cell lines.
`
`2 Materials and methods
`
`2.1 Media
`
`DF is Dulbecco's modified Eagle's medium (Gibco, Grand
`Island, NY), supplemented to contain 100 unitsiinl penicillin
`and streptomycin, 15% heat-inactivated fetal bovine serum
`2-mercaptoethanol. IF is Iscove's modified
`and 3.5 x
`Dulbecco's medium (Gibco), supplemented as above for DF
`medium. BSS-G contains 0.14 g CaC12, 8 g NaCl, 0.4 g KCl,
`0.2 g MgS04.7 H20, 0.2 g MgC12.6 H20, 0.06 g KHZP04,
`0.24 g Na2HPO4-2H20, and 0.01 g phenol red, per liter.
`T medium containing 10 g tryptone (Difco, Detroit, MI), 5 g
`NaCl, and 0.05 g yeast extract, per liter, was used for growth
`of E. Coli C3000 and plaquing of phage f 2. PBS contains 8.5 g
`NaCl, 1.28 g Na2HP04. 2 H20, and 0.386 g NaH2P04. H20,
`per liter. HAT indicates that the medium contains 13.6 mg
`hypoxanthine, 0.174 mg aminopterin, and 3.87 mg thymidine,
`per liter.
`
`2.2 Culture conditions
`
`Cells were grown in DF or IF medium. When it became neces-
`sary to grow cells either at very low density or in the presence
`of a large excess of dead cells, peritoneal exudate cells were
`added at lo5 cells/ml. These cells were prepared by flushing the
`peritoneum of a BALB/c mouse with 5 ml BSS-G. The result-
`ing cell suspension was centrifuged and washed twice in BSS-G
`and finally resuspended in medium at lo5 cells/ml.
`
`the mixtures contained rabbit anti-mouse p serum to develop
`the plaques [14]. Plaques were visible after several hours' incu-
`bation at 37°C. In general, plaques were larger in Cunning-
`ham chambers than in agarose. However, the mutant igx-215
`makes very small plaques in agarose, but no plaques (<
`plaque/cell) in Cunningham chambers.
`
`2.4 Preparation of radiolabeled Ig and analysis of
`Ig production
`
`Extracellular preparations were obtained by growing cells
`overnight in leucine-free D F medium supplemented to contain
`5 pCi (= 185 kBq) 14C-leucine/ml and 5% dialyzed fetal
`bovine serum. Cultures were centrifuged, and the supernatant
`was used as a source of secreted (extracellular) Ig. Intracellu-
`lar material was prepared by incubating the cells for 2 h in the
`above medium. Cells were harvested by centrifugation and
`lysed by the addition of 0.5% Nonidet-P 40. Where indicated,
`the extra- or intracellular material was reacted with a rabbit
`anti-mouse IgM serum to purify and concentrate the IgM.
`
`Radiolabeled Ig was analyzed by sodium dodecyl sulfate poly-
`acrylamide gel electrophoresis (SDS-PAGE) [15], IEF [16]
`and by two-dimensional IEF/SDS-PAGE [ 171. IgM production
`was also assayed by measuring lysis of protein A (Pharmacia,
`Uppsala, Sweden)-coupled red cells [14] using specific rabbit
`sera donated by Dr. F. Melchers. TNP-specific IgM was
`assayed by lysis or agglutination of TNP-coupled red cells [13].
`The sensitivity of the hemagglutination assay was increased by
`including p-specific rabbit serum (Litton Bionetics Inc., Ken-
`sington, MD). Plates for spot tests of hemolysis titer were
`prepared as described for plaquing.
`
`2.5 TNP-phage inactivation
`
`For the detection of anti-TNP activity, TNP-coupled phage f 2
`(kindly donated by Dr. H. Pohlit) was incubated with culture
`supernatants at various dilutions for 2 h at 37 "C. For measur-
`ing the affinity of the IgM for the free TNP, we used the
`method of Haimovich and Sela [18], whereby the fraction of
`IgM bound to the TNP hapten is measured by the inhibition of
`TNP-phage inactivation. The hapten TNP-caproic acid (pro-
`vided by Dr. H.-R. Kiefer) at various dilutions was preincu-
`bated for 10 min at room temperature with an appropriate
`dilution of culture supernatant. TNP-phages were then added
`and the incubation continued for 7 min at room temperature.
`After incubation, an aliquot was titered for plaques on E. Coli
`C 3000.
`
`2.3 Plaquing
`
`2.6 Classification of Ig from Sp6
`
`Plaque-forming cells (PFC) were titered either in agarose or
`Cunningham chambers [12]. For titering 2,4,6-trinitrophenyl
`(TNP)-specific cells by agarose plaquing, 2 ml of 0.6% agarose
`in PBS was added to a mixture containing 0.1 ml 25% TNP-
`coupled red cells [13], 0.1 ml guinea pig serum (@RAY,
`Behringwerke, Marburg/Lahn, FRG) and the cells to be
`titered. For plaquing in Cunningham chambers, a suspension
`containing 60 pl of the cells to be titered, 10 pl guinea pig
`serum, 20 pl of 25% TNP-coupled red cells was introduced
`into a chamber. For titering IgM-secreting cells, protein A-
`coupled red cells were used in place of the TNP-red cells, and
`
`The Ig of the hybridoma Sp 6 has been classified as IgM (n) for
`the following reasons. On SDS-PAGE, unreduced Ig has the
`mobility corresponding to a molecular mass of 920 kD, while
`the reduced Ig yields an H chain for which the mobility corre-
`sponds to 70 kD. Furthermore, the Ig from this cell line gives
`rise to direct hemolysis which is not enhanced by y-specific
`antisera and also effects direct agglutination of TNP-coupled
`red cells, and this agglutination is enhanced by p-specific anti-
`sera. The L chain has been classified as x by Ouchterlony tests
`using anti-x and -1 antisera kindly donated by Dr. A. Kelus.
`To avoid interference in this analysis by the myeloma n chain,
`
`Merck Ex. 1118, Pg. 2
`
`

`

`Eur. J. Immunol. 1980.10: 467-476
`
`Immunoglobulin M mutants
`
`469
`
`secreted material from the mutant line igm-10, which contains
`only the L chain (see Sect. 3), was reacted with these sera.
`Precipitation lines with anti-x but not with anti-h were seen.
`
`2.7 Fusion for complementation
`
`Cells of the indicated type (4.5 x lo6) grown in DF medium
`were mixed together, centrifuged (200 x g for 10 min), resus-
`pended in serum-free medium and recentrifuged. The cell pel-
`let was gently resuspended in 0.15 ml of a solution composed
`of 43% polyethylene glycol 1500 (British Drug Houses, Poole,
`GB), 43% serum-free Dulbecco's modified Eagle's medium
`(Gibco) and 14% dimethyl sulfoxide, and incubated for 2 rnin
`at 37°C. Then, 0.15 ml serum-free medium, at 37"C, was
`added over a 1-min interval, after which 20 ml serum-free
`medium at 37°C was added. The cells were incubated for
`10 min, then centrifuged and resuspended
`in 30 ml DF
`medium and incubated for 18 h. At this point, plaque-forming
`cells were titered in Cunningham chambers (3 X lo5 cells/
`chamber).
`
`2.8 Selection of mutants
`
`The mutants described here were derived from a hybridoma
`cell line that secretes IgM specific for the hapten TNP. The
`selection system involves first, attaching TNP to the mem-
`brane of the cells. Wild-type cells then secrete IgM that binds
`to the TNP on their own membrane, thus rendering the cells
`sensitive to complement (C) killing. By contrast, mutants
`unable to make TNP-specific IgM that can fix C survive the
`TNPiC treatment. The selection method described in detail
`below was devised after studying the effects of varying the
`temperature and times of incubation and TNP concentration
`and has since been used to generate mutants of the Sp603
`clone. The mutants of Sp602 were obtained using this selec-
`tion method under somewhat different conditions [2,4,6-trini-
`trobenzene sulfonic acid (TNBS) at 1.5 mglml instead of 1 mg/
`ml, incubated first cycle at approximately 23"C, second cycle
`at 4"C, both cycles for 20 min].
`To select the mutant cells, 1 x lo7 Sp 603 cells were washed in
`PBS and resuspended at 5 x lo6 cells/ml in 2 ml PBS contain-
`ing 1 mg/ml TNBS (British Drug Houses) and incubated at
`22-23 "C for 10 min, to allow TNP to attach to the cell surface.
`The cells were then diluted to 25 ml with cold PBS, cen-
`trifuged, washed once in PBS and then resuspended at 5 X 10'
`cellslml in DF medium containing 1% methyl cellulose
`(Methacel4000, Hoffmann-La Roche, Basel) and 10% guinea
`pig serum as a C source. This mixture was then incubated for
`30 min at 37°C to allow the wild-type cells to secrete IgM
`which would then bind to the TNP on the cell surface, thus
`rendering these cells sensitive to C-mediated killing. After this
`incubation, the cells were diluted to 150 ml with PBS, cen-
`trifuged, washed once in PBS and then resuspended in 6 ml
`medium. Because very few (< 1%) of the cells survived, 10'
`peritoneal exudate cellslml were added as fillericleaner cells.
`The cells were incubated for one day so that the dead cells
`would not make a plaque, after which time the cells were
`tested for their capacity to produce TNP or protein A plaques.
`The surviving cells were then grown to about lo7 cells and the
`selection repeated as above. In these subsequent TNP/C selec-
`tions, killing was not as extensive as for the original untreated
`population because the mutants comprised a greater fraction
`
`of the cells. For this reason, cells were resuspended in 15 ml
`medium without peritoneal exudate cells.
`
`To devise this selection system, we tested the effects of varying
`the TNBS concentration and incubation temperature. We
`monitored the effectiveness of the selection by treating a mix-
`ture of cells composed of a majority of Sp603 cells and a
`minority of other hybridoma cells, either the Spl/HL, Sp 2/HL,
`or Sp3/HL (which secrete sheep red cell (SRC)-specific IgM,
`IgG2,,, and IgGl, respectively) or the mutant igm-20 that has
`lost its capacity to synthesize the TNP-specific x chain (see
`Sect. 3). The extent of the enrichment for the non-TNP-
`specific cells, following the TNP/C treatment, was monitored
`by measuring the plaques on the appropriate indicator red
`cells (TNP-horse red cells, -SRC, or protein A-red cells). The
`extent of killing after the selective treatment was variable, and
`the enrichment observed was in the range of 20 to 200-fold.
`
`As described in Sect. 3, approximately 1% of the surviving
`cells secreted IgM which failed to lyse TNP-coupled red cells.
`To isolate these presumptive IgM-secreting mutants, the cells
`were cloned by one of three methods: (a) in methyl cellulose,
`over protein A-coupled red cells, in which case the IgM-pro-
`ducing clones made plaques, (b) in soft agar, in which case the
`IgM-producing clones were recognized by overlaying the col-
`onies with anti-y antiserum which caused the formation of a
`precipitate around the IgM-secreting colonies, or (c) by limit-
`ing dilution in microtiter wells, in which case the IgM-secreting
`clones were scored by testing whether culture fluid would lyse
`protein A-coupled red cells in the presence of anti-y develop-
`ing serum and C.
`
`2.9 Isolation and cloning of mutants
`
`The mutants igk-1, igm-12, and igm-21 were obtained from the
`Sp602 clone as follows. The Sp602 cells that survived two
`cycles of TNP coupling and C treatment were cloned and
`plaqued in methyl cellulose in 35-mm dishes, as follows. A
`1-ml layer containing 0.5% indubiose in DF medium (igk-1,
`igm-12) or IF medium (igm-21) was used to provide a flat
`surface. Over this was layered 0.2 ml of 0.3% agarose (L'In-
`dustrie Biologique FranGaise S. A., Genevillier, France) in the
`corresponding medium containing 10 yl C (lyophilized guinea
`pig C: BRAY, Behringwerke) and 10 ~1 SRC coupled with
`protein A (for the isolation of igk-i and igm-12) or TNP (for
`the isolation of igm-21). Finally, 1 ml of 1% methyl cellulose
`in medium containing the surviving Sp602 cells was added.
`Plates were incubated for 2-3 days, after which time the PFC
`were transferred with a micropipet to 15 pl medium containing
`lo5 peritoneal exudate cells/ml. These isolates were then incu-
`bated and diluted until they had grown to lo6 cells. Isolates
`secreting Ig which differed from wild type were then recloned
`in soft agar [lo].
`
`The mutant igx-215 was obtained from the Sp603 clone as
`follows. After subjecting the Sp 603 cells to three cycles of
`TNP coupling and C treatment, we attempted to enrich for
`these IgM producers by using the FACS: cells were exposed to
`a rabbit antiserum and then stained with a fluorescein-labeled
`sheep anti-rabbit antiserum. Approximately 1% of the cells
`were stained, passed through the sorter, and the brightest 2%
`of the cells were cultured further. Whereas approximately
`50% of the cells in this preparation were stained by the anti-y
`treatment, only 1% of the cells secreted IgM, as measured by
`
`Merck Ex. 1118, Pg. 3
`
`

`

`470
`
`G. Kohler and M. J. Shulman
`
`Eur. J. Immunol. 1980. 10: 467-476
`
`the frequency of protein A plaques, implying that the FACS
`sorting led to no enrichment for IgM-secreting cells. Neverthe-
`less, this preparation was cloned by plating the cells in 35 mm
`dishes in 0.2 ml 0.22% agarose in D F medium layered over
`1.5 ml 0.5% agarose in D F medium. After 1 week, the col-
`onies were scored for IgM secretion by overlayering 0.2 ml
`containing 0.17% agarose, 1.4-fold concentrated Dulbecco's
`modified Eagle's medium and 8 pl rabbit anti-y antiserum.
`After 1 day, colonies surrounded by a precipitate were trans-
`ferred to 0.1 ml DF medium and grown to mass culture.
`
`Culture fluid from 15 such isolates lysed protein A- but not
`TNP-coupled red cells; in SDS-PAGE, the H and L chains
`appeared to be normal. The IEF pattern of 6 of these mutants
`was the same as for wild type. We supposed that these isolates
`all derived from the same initial variant cell and limited our
`analysis to reclones igx-209 and igx-215 of one such isolate.
`
`The mutant igm-692 was isolated as follows. The Sp603 cells
`which survived 4 cycles of TNP coupling and C treatment were
`diluted to a concentration of 20 cellsiml, in D F medium sup-
`plemented to contain 2000 HAT-sensitive BW 5147 cells/ml
`added as filler cells. This mixture was distributed in 0.1 ml
`aliquots in microtiter wells. After 3-4 days, the HAT-sensitive
`BW 5147 cells were killed by adding 0.1 ml HAT-sup-
`plemented D F medium. Supernatants were tested for IgM by
`spotting them onto a protein A-SRC indicator layer. After
`about 1 week, the hybridoma cells had grown to high density
`and were transferred to fresh HAT-containing medium. For
`the following 2 weeks, they were diluted in HT-containing DF
`medium and finally, in normal DF medium. Three mutant
`isolates were found to have the property of secreting an H
`chain of the same higher than normal mobility in SDS-PAGE.
`One such isolate, igm-692, was selected for further analysis.
`
`3 Results
`3.1 Derivation of the wild-type cell line
`
`the low secretion of K. In contrast to the secreted material
`which contains a low amount of K, comparable amounts of K
`and L are observed in intracellular preparations. Similarly,
`cell-free in vitro synthesis directed by mRNA of Sp602 cells
`yielded equal amounts of K and L (Hirama and Kohler,
`unpublished results). These results suggest that the low level
`of K secretion does not reflect a defect in K synthesis. The K
`chain can only be secreted when attached to an H chain [19],
`whereas L can also be secreted alone. The differences in
`amount of K secreted by the reclones of Fig. 1 might, there-
`fore, be explained either by enhanced degradation of K or by
`reduced affinity of K for the H chains.
`
`Figure I. Ig from Sp6 clones. Radio-
`labeled culture supernatants of Sp 6 clones
`were reduced and analyzed by SDS-
`PAGE as described in Sect. 2.4.
`
`3.2 Enrichment for mutants altered in Ig production
`
`The selection scheme is designed to enrich for mutants that
`secrete either less IgM or else IgM that is reduced in TNP
`binding or C fixation (see Sect. 2.8). To effect this selection,
`the population of cells is treated so that TNP is covalently
`bound to the cell membrane. Under conditions of limited dif-
`fusion, the wild-type cells secrete IgM that binds to the TNP
`on their own membrane, so that in the presence of C, the wild-
`type cells are killed. By contrast, the mutants survive this
`treatment and are thus enriched.
`
`I
`
`Fig. 1 shows the SDS-PAGE pattern of Ig from 7 TNP-specific
`. -
`clones derived from the original Sp6 pot. Two kinds of sub-
`clones were observed: those, such as C2, which secrete com-
`parable amounts of the TNP-specific (L) and nonspecific (K)
`light chains, and those, such as Al, which secrete less K. For
`several reasons, we consider the C 2 type to be the parental
`phenotype and A1 a subsequent variant: most hybridomas
`obtained with X63-Ag8 are of the C2, rather than A1 type.
`Furthermore, of 8 reclones of Sp 6-C 2, 6 showed the parental
`C 2 phenotype, whereas 2 secreted a low level of K, similar to
`the Sp6-A1 phenotype. By contrast, all of the 48 reclones of
`Sp6-A1 had the low level K phenotype. One clone (Sp6-AI-
`14) did not express the y chain and was recloned twice. From
`this second recloning, we obtained the clones Sp602 and
`Sp 603 from which the mutants described below were derived
`(see also Scheme 1).
`In the course of these experiments, we have made several
`observations which might help to understand the reason for
`
`cells were titered by measuring plaques on TNP-coupled red
`').
`
`Randomly picked clones of twice-treated Sp 602 revealed that
`the non-plaque-forming population consisted of cells which do
`not express the p chain (see description of igm-10). Prior to the
`selection, these y- variants would be expected to represent
`about 1% of the cells [20]; in fact, screening of 185 reclones of
`untreated Sp 603 revealed one such y- variant. After several
`cycles of this selective treatment, the frequency of IgM-pro-
`ducing (protein A PFC) among the y- cells was 1% (Table 1,
`bottom line). This fraction includes mutant cells making
`altered IgM as well as wild-type cells. The frequency of wild-
`type cells is estimated by TNP plaque formation to be less than
`0.003% for the Sp603 populations. Assuming that the ratio of
`mutant cells to y- cells is the same before and after selection,
`we estimate the frequency of the mutants among wild-type
`cells in the original population to be:
`(Mutantdp-) X (y-/wild type) = 0.01 x 0.01 = 1 x
`
`Merck Ex. 1118, Pg. 4
`
`

`

`Eur. J. Immunol. 1980. 10: 467-476
`
`Table 1. Effect of suicide selection")
`
`Line
`
`sp 602
`
`s p 603
`
`Selection
`round
`
`0
`1
`2
`0
`1
`2
`3
`4
`
`Survival
`
`TNP plaques
`
`( %)
`-
`0.2
`30
`
`n.d.
`n.d.
`n.d.
`n.d.
`
`(%)
`
`100
`4
`1
`100
`56
`3.5
`0.w
`5 0.003
`
`Prot. A
`plaques
`(Q)
`
`100
`6
`4
`1 (X)
`70
`7
`4
`I
`
`a) The population of Sp 602 or Sp 603 cells was subjected to the TNP/
`C selection (see Sect. 2.8). The plaque-forming capacity is ex-
`pressed as plaquesicell surviving the selection, divided by plaques/
`cell of the untreated population. Plaques were measured in Cun-
`ningham chambers. The protein A plaques reveal cells secreting
`IgM irrespective of its antigen-binding capacity; TNP plaques
`depend on cells secreting TNP-specific IgM. n.d. = not deter-
`mined.
`
`3.3 Isolation of variants
`
`As described above, the selected population was comprised
`mainly of p- variants, and in order to reveal IgM-secreting
`clones, several approaches have been used. In the case of the
`twice-treated Sp 602 population (Table l), mutants still mak-
`ing IgM were sought by plating the cells in methyl cellulose for
`protein A plaques with p-specific developing serum. Assuming
`that there might be mutants making IgM that retained some
`TNP-binding activity, cells were also plated for TNP plaques
`(see Sect. 2.3). Of 15 clones derived from TNP plaques, only
`
`Table 2. Properties of the mutant cell lines")
`
`Immunoglobulin M mutants
`
`471
`
`one (igm-21) behaved differently from the wild-type line. Of
`the 20 clones picked from the center of protein A plaques, 12
`could be grown to mass culture. Three kinds of variants could
`be isolated (igk-1, isolated 10 times, igk-20, isolated once, and
`igm-12, isolated once, see also Scheme 1).
`After 4 cycles of suicide selection of Sp603, 26 clones were
`selected reacting with specific rabbit anti-mouse-p serum (see
`Sect. 2.3). Of these, 5 were found to be of the igk-1 type, and
`3 of the igk-20 type. Two new kinds of variants were found;
`igx-215 (isolated 15 X ) and igm-692 (isolated 3 X). All isolates
`were recloned before analysis. The mutants were then sub-
`jected to various tests to measure IgM production and antigen
`binding (Table 2 and Fig. 2).
`
`3.4 Mutants affecting L chain production
`
`igk-20. The IgM secreted by this cell line has no TNP-binding
`activity when assayed by hemagglutination or hemolysis of
`TNP-coated SRC, or by the more sensitive assay of inactiva-
`tion of TNP-conjugated phage f 2 (Table 2). SDS-PAGE
`analysis of intra- and extracellular reduced material indicates
`that this mutant makes no TNP-specific L chain (Fig. 2 a). By
`contrast, the myeloma K chain is synthesized and secreted in
`amounts characteristic of the parent Sp6MLGK (C2 type,
`Fig. 1) cell line. In Sect. 4, we shall return to the question of
`why the mutations expressing no L chain should occur less
`frequently than mutants making no p chain.
`
`igk-1. This mutant makes a small amount of the TNP-specific
`L chain, intra- as well as extracellularly, and secretes larger
`amounts of K than the parental lines (Figs. 2 and 3). Among
`64 clones derived from igk-1, two (igk-1-1, igk-1-2) had lost p
`expression (Fig. 3). The result shows that the K chain has
`retained its parental trait not to be secreted as free K.
`
`Line
`
`Prot. A lysis
`
`sp 603
`
`igm-12
`igm-692
`igx-215
`igx-209
`igk-l
`igk-20
`igm-I0
`
`1:25
`
`1 :2'
`1 :23
`1:2"
`1:P
`1 :25
`1 :25
`none
`
`TNP aggl.
`Direct
`Indirect
`(%,
`(%)
`loo
`(1:26)
`2s
`< 6
`< 2
`< 2
`< 2
`< 2
`< 2
`
`100
`(1:21")
`50
`6
`3
`1
`2
`<0.2
`<0.2
`
`TNP lysis
`
`TNP plaques
`
`(c/.)
`
`100%
`(1:2")
`< 2%"
`< 2%
`< 0.4%
`< 0.4%
`(0.4%
`< 0.3%
`< 0.4%
`
`1 h'
`
`2 x 10 I
`< 1 x lo->
`1 x 1 0 I
`4 x 10-j
`1 x 10-5
`3 x 10
`n.d.
`
`TNP-phage
`inactivation
`(5%)
`
`Frequency of
`occurrence
`in Sp602 in Sp603
`
`100
`
`80
`8
`60
`40
`5
`< 0.2
`< 0.2
`
`1/12
`o/ 12
`n.d.
`0/12
`10/12
`1/12
`n.d.
`
`0126
`3/26
`n.d.
`15/36
`5/26
`3/26
`n.d.
`
`a) The radiolabeled culture supernatants analyzed in Fig. 2 were tested as follows. For the columns protein A lysis, TNP
`aggl., and TNP lysis, the dilution endpoint of lysis or agglutination was measured. For TNP-phage inactivation, the
`supernatant concentration resulting after 2 h incubation at 37°C in SO% inactivation of TNP-coupled phage f 2 was taken.
`To compare the activity per unit IgM for mutant and wild-type culture supernatants, the protein A lysis titer was taken as a
`measure of total IgM concentration. The values presented for TNP aggl., TNP lysis, TNP-phage inactivation were
`calculated as:
`Mutant titerimutant protein A lysis titer
`x 100.
`Wild-type titedwild-type protein A lysis titer
`The numbers in parentheses are the wild-type titers. TNP plaques give the plaquesicell obtained by the mutant cells
`divided by the TNP plaqueskell of the wild-type culture. Plaquing was done in agarose. The last 2 columns indicate how
`often a particular mutant phenotype was revealed in the primary isolates after the suicide selection.
`b) 160 plaques/103 cells.
`c) 1-376 TNP-lysis activity was observed in other preparations.
`
`Merck Ex. 1118, Pg. 5
`
`

`

`472
`
`G. Kohler and M. J. Shulman
`
`Eur. J. Immunol. 1980. 10: 467-476
`
`In contrast to igk-20 IgM, the TNP-binding activity is easily
`detected by
`the inactivation of TNP-coupled phage f 2
`(Table 2); from this, we argue that igk-1 must be making some
`TNP-specific L. We have also analyzed the L chains secreted
`by igk-1 in two-dimensional electrophoresis using first IEF and
`then SDS-PAGE. Material moving to the region characteristic
`of L and K on IEF also moves to the characteristic region on
`SDS-PAGE implying that both chains are indistinguishable
`from the corresponding parental L and K (Fig. 4). The igk-1
`cell line gave TNP-specific plaques at an efficiency lo5 lower
`than the parental cell line suggesting that this mutant is quite
`stable (Table 2).
`
`3.5 Mutants affecting p chains
`
`igm-10. Both intra- and extracellular preparations were found
`by SDS-PAGE to lack p (Fig. 2). The myeloma K chain is not
`secreted except when bound to an H chain [19] and, therefore,
`is observed only in intracellular preparations but not in the
`secreted material. Membrane staining with anti-mouse
`p-specific, fluoresceinated rabbit serum did not reveal any
`positive cells among 5000 cells examined.
`
`igm-21. We have analyzed the Ig made by the mutant igm-21
`in several ways. Extra- and intracellular preparations were
`reacted with rabbit anti-mouse IgM serum, which was largely
`specific for the mouse p chain. SDS-PAGE of the reduced
`precipitates indicated that igm-21 makes a smaller amount of 1
`
`Figure 2. Extra- and intracellular Ig of mutant clones. Radiolabeled
`culture supernatants (extra) and intracellular preparations were
`reacted with rabbit anti-mouse IgM. The precipitate was solubilized
`and analyzed by SDS-PAGE under (a) reducing and (b) nonreducing
`conditions. (The mutant igx-833 is an isolate that behaved like igx-215;
`Sp 2515-1-Ag5 was included as IgG reference protein.)
`
`Figure 3. Ig production by igk-1. Radiolabeled culture supernatants
`(extra) and intracellular preparations were reacted with rabbit anti-
`mouse IgM, and the resulting preclpitates were reduced and analyzed
`by SDS-PAGE.
`
`Figure 4. Two-dimensional gel electrophoresis of igk-1. First dimen-
`sion IEF from pH 5 (left) to 9 (right) of the radiolabeled and reduced
`igk-1 Ig. The igm-10 L chain is shown as reference. Both samples were
`run side by side on an IEF glass plate, fixed, dried and autoradio-
`graphed. The strip of gel containing the igk-1 Ig was located with the
`help of the autoradiograph of the IEF pattern, peeled off the plate,
`and subjected to SDS-PAGE under reducing conditions [ 171.
`
`chain (Fig. 5). Most L chains were not precipitated by the
`antiserum and remained in the supernatant. Small aliquots of
`the supernatants wer

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket